# EDGAR Filing Document

**Accession Number:** 0001776738
**File Stem:** 0001140361-23-014604
**Filing Date:** 2023-3
**Character Count:** 8013
**Document Hash:** 261a9fc0e982895310394dc0239bc78f
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001140361-23-014604.hdr.sgml**: 20230329

**ACCESSION NUMBER**: 0001140361-23-014604

**CONFORMED SUBMISSION TYPE**: 4

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20230327

**FILED AS OF DATE**: 20230329

**DATE AS OF CHANGE**: 20230329

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** ABBOTT MICHAEL
- **CENTRAL INDEX KEY:** 0001400413

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 000-56294
- **FILM NUMBER:** 23776947

**MAIL ADDRESS:**
- **STREET 1:** C/O COLUMBIA CARE INC.
- **STREET 2:** 680 FIFTH AVENUE, 24TH FLOOR
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10019
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Columbia Care Inc.
- **CENTRAL INDEX KEY:** 0001776738
- **STANDARD INDUSTRIAL CLASSIFICATION:** AGRICULTURE PRODUCTION - CROPS [0100]
- **IRS NUMBER:** 981488978
- **STATE OF INCORPORATION:** A1
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** 680 FIFTH AVENUE, 24TH FLOOR
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10019
- **BUSINESS PHONE:** 2125543424

**MAIL ADDRESS:**
- **STREET 1:** 680 FIFTH AVENUE, 24TH FLOOR
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10019

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 4

### STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

[ ] Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>ABBOTT MICHAEL<br><sub>(Last) (First) (Middle)</sub><br>C/O COLUMBIA CARE INC.<br>680 FIFTH AVENUE, 24TH FLOOR<br><sub>(Street)</sub><br>NEW YORK, NY 10019<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2023-03-27 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[X] Director [ ] 10% Owner<br>[X] Officer (give title below) [ ] Other (specify below)<br>_Chairman_ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>Columbia Care Inc. [ CCHW ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | 3. Transaction Code (V) | 3. Transaction Code (V) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | Code | V | Amount | (A) or (D) | Price | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| Common Shares | 2023-03-27 |  | M |  | 468605 | A | <sup>(1)(2)</sup> | 1229961 | D |  |
| Common Shares | 2023-03-27 |  | M |  | 319523 | A | <sup>(1)(3)</sup> | 1549484 | D |  |
| Common Shares | 2023-03-27 |  | M |  | 168990 | A | <sup>(1)(4)</sup> | 1718474 | D |  |
| Common Shares | 2023-03-27 |  | M |  | 51239 | A | <sup>(1)(5)</sup> | 1769713 | D |  |
| Common Shares | 2023-03-27 |  | M |  | 633051 | A | <sup>(6)</sup> | 2402764 | D |  |

---

## Table II - Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | 4. Transaction Code (V) | 4. Transaction Code (V) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 6. Date Exercisable and Expiration Date | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Underlying Securities | 7. Title and Amount of Underlying Securities | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| Restricted Stock Units | <sup>(1)</sup> | 2023-03-27 |  | M |  |  | 468605 | <sup>(2)</sup> | <sup>(2)</sup> | Common Shares | 468605 | $0 | 0 | D |  |
| Restricted Stock Units | <sup>(1)</sup> | 2023-03-27 |  | M |  |  | 319523 | <sup>(3)</sup> | <sup>(3)</sup> | Common Shares | 319523 | $0 | 0 | D |  |
| Restricted Stock Units | <sup>(1)</sup> | 2023-03-27 |  | M |  |  | 168990 | <sup>(4)</sup> | <sup>(4)</sup> | Common Shares | 168990 | $0 | 0 | D |  |
| Restricted Stock Units | <sup>(1)</sup> | 2023-03-27 |  | M |  |  | 51239 | <sup>(5)</sup> | <sup>(5)</sup> | Common Shares | 51239 | $0 | 0 | D |  |
| Restricted Stock Units | <sup>(6)</sup> | 2023-03-27 |  | M |  |  | 633051 | <sup>(6)</sup> | <sup>(6)</sup> | Common Shares | 633051 | $0 | 0 | D |  |

---

### Footnotes:

(1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.

(2) The RSUs were granted on March 31, 2022, and vested 1/4 annually beginning March 31, 2023, with settlement to occur as soon as practicable following the applicable vesting date. Vesting was accelerated as a result of a termination and release of claims agreement between the Issuer and the reporting person dated March 15, 2023 (the"Agreement").

(3) The RSUs were granted on March 23, 2021, and vested 1/4 annually beginning March 23, 2022, with settlement to occur as soon as practicable following the applicable vesting date. Vesting was accelerated pursuant to the Agreement.

(4) The RSUs were granted on March 31, 2020, and vested 1/4 annually beginning March 31, 2021, with settlement to occur as soon as practicable following the applicable vesting date. Vesting was accelerated pursuant to the Agreement.

(5) The RSUs were granted on September 30, 2019, and vested 1/4 annually beginning April 29, 2020, with settlement to occur as soon as practicable following the applicable vesting date. Vesting was accelerated pursuant to the Agreement.

(6) The performance stock units ("PSUs") were granted on March 31, 2020, and March 23, 2021. Each PSU represents a contingent right to receive one share of the Issuer's common stock. Vesting was accelerated pursuant to the Agreement.

**Signature:** /s/ David Sirolly as attorney-in-fact for Michael Abbott  
**Date:** 2023-03-29

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**